medigraphic.com
SPANISH

Revista Mexicana de Anestesiología

ISSN 3061-8142 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
    • Políticas éticas
    • Políticas editoriales generales
    • Políticas de revisión de manuscritos
    • Políticas de acceso abierto
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number S1

<< Back Next >>

Rev Mex Anest 2026; 49 (S1)

Management of intraoperative bleeding in patients with severe burns

Macías-Pérez J
Full text How to cite this article

Language: Spanish
References: 12
Page: 426-428
PDF size: 723.98 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Hebert PC, Van der Linden P, Biro G, Hu LQ. Physiologic aspects ofanemia. Crit Care Clin. 2004;20:187-212.

  2. Pieracci FM, Henderson P, Rodney JR, et al. Randomized, double blind,placebo-controlled trial of effects of enteral iron supplementation onanemia and risk of infection during surgical critical illness. Surg Infect(Larchmt). 2009;10:9-19.

  3. Palmieri TL, Greenhalgh DG, Sen S. Prospective comparison of packedred blood cell-to-fresh frozen plasma transfusion ratio of 4: 1 versus1: 1 during acute massive burn excision. J Trauma Acute Care Surg.2013;74:76-83.

  4. Sterling JP, Heimbach DM. Hemostasis in burn surgery – a review.Burns. 2011;37:559-565.

  5. Sheridan RL, Szyfelbein SK. Staged high-dose epinephrine clysis is safeand effective in extensive tangential burn excisions in children. Burns.1999;25(8):745-748.

  6. Foster KN, Mullins RF, Greenhalgh DG, et al. Recombinant humanthrombin: safety and immunogenicity in pediatric burn wound excision.J Pediatr Surg. 2011;46:1992-1999.

  7. Carrillo Esper R, Tamez Coyotzin A, Garnica Escamilla MA,Sánchez Pérez H, Carrillo Córdova DM, Carrillo Córdova CA.Alteraciones de la hemostasia en el enfermo con quemaduras. MedCrít. 2018;32:41-47.

  8. Glas GJ, Levi M, Schultz MJ. Coagulopathy and its management inpatients with severe burns. J Thromb Haemost. 2016;14:865-874.

  9. Rossaint R, Bouillon B, Cerny V, et al. The European guideline onmanagement of major bleeding and coagulopathy following trauma:fourth edition. Crit Care. 2016;20:100.

  10. McCormack PL. Tranexamic acid: a review of its use in the treatmentof hyperfibrinolysis. Drugs. 2012;72:585-617.

  11. CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R,Caballero J, Coats T, et al. Effects of tranexamic acid on death,vascular occlusive events, and blood transfusion in trauma patientswith significant haemorrhage (CRASH-2): a randomised, placebocontrolledtrial. Lancet. 2010;376:23-32. doi: 10.1016/S0140-6736(10)60835-5.

  12. Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N,et al. The European guideline on management of major bleeding andcoagulopathy following trauma: sixth edition. Crit Care. 2023;27:80.doi: 10.1186/s13054-023-04327-7.




CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Anest. 2026;49